Evidence map›Paper›PMID 39834419›Full record

ArticleHeliyon2025

BioHastalex modified with silver nanolayers and heat treatment for antibacterial properties.

Nikola Slepičková Kasálková, Silvie Rimpelová, Cyril Vacek, Bára Frýdlová, Iva Labíková, Jan Plutnar, Kamil Severa, Václav Švorčík, Petr Slepička

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nikola Slepičková KasálkováDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Silvie RimpelováDepartment of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Cyril VacekDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Bára FrýdlováDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Iva LabíkováDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Jan PlutnarDepartment of Inorganic Chemistry, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Kamil SeveraDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Václav ŠvorčíkDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Petr SlepičkaDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we present surface analysis and biocompatibility evaluation of novel composite material based on graphene oxide traded as BioHastalex. The pristine material's surface morphology and surface chemistry were examined by various analytical methods. The BioHastalex with a thin silver layer was subsequently heat treated and characterized, the impact on the material surface wettability and morphology was evaluated. Significant surface roughness and morphology changes were detected at the nanometer scale after heat treatment of Ag-sputtered BioHastalex. The deposition of a thin silver nanolayer had an outstanding effect on BioHastalex's antibacterial properties while still maintaining cell viability (MRC-5, HaCaT). The heat treatment of BioHastalex-Ag led to the formation of regular nanocluster arrays while affecting the Ag concentration on the very surface. The decrease in silver concentration was connected with the length of heat treatment; cells growing on such samples exhibited good viability, and the antibacterial properties were weaker than simply sputtered BioHastalex.

Indexed as

BioHastalexCytocompatibilityGraphene compositeMorphologyNanostructurePolymer stabilitySurface chemistrySurface modification

Identifiers

PMID39834419
PMCPMC11742824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.